INmune Bio Market Cap

INmune Bio has a market cap or net worth of $50.78 million as of December 5, 2025. Its market cap has decreased by -52.97% in one year.

Market Cap

50.78M

Enterprise Value

24.12M

1-Year Change

-52.97%

Ranking

#4580

Market Cap Chart

Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $50.78M, a decrease of -34.75%. That is a compound annual growth rate of -6.06%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	49.98M	-51.73%
Dec 31, 2024	103.55M	-48.97%
Dec 29, 2023	202.92M	78.35%
Dec 30, 2022	113.78M	-37.49%
Dec 31, 2021	182.00M	-21.41%
Dec 31, 2020	231.57M	270.69%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	936.68B
Johnson & Johnson	494.92B
AbbVie	396.55B
UnitedHealth Group	293.98B
AstraZeneca	282.37B
Novartis AG	253.36B
Merck & Co.	250.76B
Abbott Laboratories	219.65B

Market Cap Rankings